Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus
- PMID: 32851373
- PMCID: PMC7406170
- DOI: 10.46497/ArchRheumatol.2020.7583
Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus
Abstract
Objectives: This study aims to evaluate the frequency and clinical and laboratory features of interstitial lung disease (ILD) in Chinese patients with systemic lupus erythematosus (SLE) and to evaluate the association of ILD with the clinical features.
Patients and methods: The study included 505 SLE patients (64 males, 441 females; mean age 35.3±15.3 years; range, 14 to 87 years) who were categorized into two groups as 449 patients without ILD and 56 patients with ILD based on evidence obtained from high-resolution computed tomography images. The demographic data, clinical and laboratory findings, SLE disease activity index score, and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index of all patients were also recorded and statistically analyzed.
Results: The ILD frequency in patients with SLE was 11.1%. Compared to the group of SLE patients without ILD, the group of SLE patients with ILD possessed the following statistical differences: elderly age, longer illness duration, lower level of anti-double-stranded deoxyribonucleic acid, and higher level of serum complement 3, increased ratios of Raynaud's phenomenon, moist rales and tachypnea. Multivariate logistic regression results suggested that elderly age (≥60 years), long illness duration (1-10 years, ≥10 years), Raynaud's phenomenon, and tachypnea were statistically associated with the occurrence of ILD in SLE patients.
Conclusion: Chinese SLE patients who possessed the factors that were statistically associated with ILD, namely, elderly age (≥60 years old), long illness duration (≥1 years), Raynaud's phenomenon, and tachypnea, were recommended to be monitored for the possibility of ILD.
Keywords: Interstitial lung disease; systemic lupus erythematosus.
Copyright © 2020, Turkish League Against Rheumatism.
Conflict of interest statement
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Similar articles
-
[Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia].Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Mar 4;53(2):266-272. doi: 10.19723/j.issn.1671-167X.2021.02.006. Beijing Da Xue Xue Bao Yi Xue Ban. 2021. PMID: 33879896 Free PMC article. Chinese.
-
Investigating the potential associated factors and developing a risk model for interstitial lung disease in Chinese patients with systemic lupus erythematosus.Lupus. 2023 Jul;32(8):993-1000. doi: 10.1177/09612033231182747. Epub 2023 Jun 20. Lupus. 2023. PMID: 37338524
-
Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases.Respirology. 2024 Aug;29(8):713-721. doi: 10.1111/resp.14703. Epub 2024 Mar 17. Respirology. 2024. PMID: 38494831
-
Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.Semin Arthritis Rheum. 2018 Oct;48(2):198-204. doi: 10.1016/j.semarthrit.2018.01.010. Epub 2018 Jan 31. Semin Arthritis Rheum. 2018. PMID: 29550111 Free PMC article.
-
Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort.Lupus. 2022 Feb;31(2):246-255. doi: 10.1177/09612033211069765. Epub 2022 Jan 16. Lupus. 2022. PMID: 35037500 Review.
Cited by
-
Respiratory Manifestations in Systemic Lupus Erythematosus.Pharmaceuticals (Basel). 2021 Mar 18;14(3):276. doi: 10.3390/ph14030276. Pharmaceuticals (Basel). 2021. PMID: 33803847 Free PMC article. Review.
-
Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?Int J Mol Sci. 2023 May 28;24(11):9388. doi: 10.3390/ijms24119388. Int J Mol Sci. 2023. PMID: 37298342 Free PMC article. Review.
-
Sexual Dimorphism in Interstitial Lung Disease.Biomedicines. 2022 Nov 24;10(12):3030. doi: 10.3390/biomedicines10123030. Biomedicines. 2022. PMID: 36551792 Free PMC article. Review.
-
Immune-mediated lung diseases: A narrative review.Front Med (Lausanne). 2023 Apr 6;10:1160755. doi: 10.3389/fmed.2023.1160755. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37089604 Free PMC article. Review.
-
Risk factors of diffuse alveolar hemorrhage in Chinese patients with systemic lupus erythematosus.Sci Rep. 2023 Dec 16;13(1):22381. doi: 10.1038/s41598-023-49978-2. Sci Rep. 2023. PMID: 38104153 Free PMC article.
References
-
- Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med. 2004;25:549–559. - PubMed
-
- Ytterberg AJ, Joshua V, Reynisdottir G, Tarasova NK, Rutishauser D, Ossipova E, et al. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation. Ann Rheum Dis. 2015;74:1772–1777. - PubMed
-
- Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733–748. - PMC - PubMed
LinkOut - more resources
Full Text Sources